1. ICAP Data Dissemination: Master Slide Deck
Data through September 30, 2012

2. How to move slides to your presentation without having to reformat
Right click on desired slide(s) and select “copy”
In your presentation, right click,
and select
OR you can click on the small clipboard
below the slide (appears after you
paste) and select
Keep source formatting
Keep source formatting

3. Number of selected activities at supported facilities,
Site Census
Number of selected activities at supported facilities,
as of September 30, 2012
Number of facilities
Updated
Definitions
Care and treatment: HIV care is defined as comprehensive palliative care to pre-ART and ART patients, which includes routine follow up visits, CD4 testing, and cotrimoxazole prophylaxis for opportunistic infections. HIV treatment is defined as provision of antiretroviral treatment. Facilities only providing pediatric care and treatment should be included in this category. Programs that provide only ART prophylaxis to pregnant women or that provide care and treatment services within TB clinics should NOT be included here.
PMTCT: PMTCT activities include, at a minimum, HIV testing in an antenatal care setting and, for HIV-infected women, provision of ARV prophylaxis. The ARV prophylaxis should be available and provided in the antenatal care setting.
Early infant diagnosis: Early infant diagnosis is defined as obtaining dried blood spots (DBS) or venous blood samples from HIV-exposed infants for DNA PCR testing. DBS can be provided in a variety of settings including antenatal care, maternal and child health (MCH) clinics, or HIV care and treatment, but to be counted as a site that provides early infant diagnosis, the sample collection must be done on-site. The processing of the sample, however, need not be done on site. Do not include this activity if HIV-exposed infants are referred off-site for DBS or venous blood collection.
TB screening among HIV patients (TB/HIV): This category refers to screening for and diagnosis of active TB among HIV-infected patients enrolled in an ICAP-supported HIV care and treatment facility. Training of clinicians on methods of active TB screening and diagnosis and support to improve the recording of information related to this screening and diagnosis should be among the support provided.
HIV testing among TB patients (HIV/TB): This category refers to support for HIV testing at TB treatment facilities in sites where ICAP supports the care and treatment facility. TB Model Centers directly supported by ICAP should also be included here.
Testing and counseling: Testing and counseling includes HIV counseling and testing services offered at out-patient or in-patient departments (adult or pediatric) by clinical staff or lay staff, often referred to as PICT (Provider-initiated Counseling and Testing) or PIHCT (Provider Initiated HIV Counseling and Testing), as well as counseling and testing services offered as part of VCT. Do NOT include counseling and testing services offered in PMTCT or TB facilities.
Laboratory support: Laboratory support is defined as the development and strengthening of laboratory facilities to support HIV/AIDS and TB-related activities. At a minimum this includes staff training and technical assistance, such as setting up infant diagnosis systems, advising on quality assurance for HIV rapid testing or for CD4 testing, and site supervision. In addition to these elements, laboratory support may include renovations, selection and procurement of equipment and commodities for chemistry analysis that are appropriate in resource limited setting. The laboratories may or may not be co-located at a site where ICAP provides other support (i.e. for care and treatment, PMTCT). Free-standing laboratories should also be included here (i.e. National Reference Laboratory in Rwanda or National Health Laboratory Services in South Africa) and added as new sites.
Source: ICAP Site Census, December 2012
Note: Some facilities offer more than one activity.

4. Number of facilities by country,
as of September 30, 2012
Number of facilities
Source: ICAP Site Census, December 2012

5. Care and treatment indicators

6. Care and treatment clinics ever supported

7. Cumulative enrollment in HIV care and treatment, by quarter
As of September 2012:
1,612,642 enrolled in care
833,712 initiated ART
1,244 clinics
Number of patients
Number of clinics
Source: ICAP URS December 2012.
Note: Includes adults and children. Data are from all clinics ever supported.

8. Cumulative pediatric enrollment in HIV care and treatment, by quarter
As of September 2012:
148,248 enrolled in care
75,140 initiated ART
1,244 clinics
Number of patients
Number of clinics
Up S
Source: ICAP URS December 2012.
Note: Data are from clinics ever supported.

9. Care and treatment clinics currently supported

10. Care and treatment clinics reporting,
as of September 30, 2012 up
Source: ICAP URS December 2012.

11. Cumulative enrollment in HIV care and treatment,
by quarter
As of September 2012:
751,407 enrolled in care
431,242 initiated ART
806 clinics
Number of patients
Number of clinics
Up S ,124
Source: ICAP URS December 2012.
Notes: Includes adults and children. Data are only from clinics currently supported and reporting.

12. Cumulative pediatric enrollment in HIV care and treatment, by quarter
As of September 2012:
65,361 enrolled in care
39,033 initiated ART
806 clinics
Number of patients
Number of clinics
S22
Source: ICAP URS December 2012.
Note: Data are only from clinics currently supported and reporting.

13. New enrollment in HIV care and treatment, by quarter
From July-September 2012:
37,187 enrolling in care
21,807 initiating ART
802 clinics
Number of patients
Number of clinics Up
S SA Oct 04, Moz, Rwanda Jan 2005, TZ Jul 2005 , Eth Oct 2005, Nig Jan 06, Ken Apr 06, CI Jan 08, Swa Jan 09
Source: ICAP URS December 2012.
Note: New enrollment includes adults and children. New on treatment include patients who transfer in already on ART. Data are only from clinics currently supported and reporting.

14. Age and sex distribution of patients enrolled in care, by country, as of September 30, 2012
Percent of patients
S29a up
Source: ICAP URS December 2012
Notes: Data are only from clinics currently supported and reporting.

15. Age and sex distribution of patients initiating ART,
by country, as of September 30, 2012
Percent of patients
S31 up
Take home message:
The patient population varies across ICAP-supported countries, reflecting differences in the epidemic as well as differences in entry points. Overall, 9% of our patient population are children under 15. Note that a smaller proportion of children (10% v.s. 11.0%) are on ART, likely reflecting difficulties making diagnosis of HIV infection in children.
Source: ICAP URS December 2012
Notes: Data are only from clinics currently supported and reporting.

16. Percent of pediatric patients
Age distribution of pediatric patients enrolled in care, by country, as of September 30, 2012
Percent of pediatric patients
S32 Take home message:
Most pediatric patients receiving HIV care were under 5 years of age (41%). In Nigeria, Swaziland and Zambia, the majority of pediatric patients were under 1.
Source: ICAP URS December 2012
Notes: Data are only from clinics currently supported and reporting.

17. Percent pediatric patients on ART
Age distribution of pediatric patients initiating ART, by country, as of September 30, 2012
Percent pediatric patients on ART
s33
Take home message:
There is large variability for proportion of <1 year enrolled in ART across countries. This is likely a reflection of the variation in the availability of early infant diagnosis. Note that the proportion of patients <1 year in ART care is about half of that in HIV care (22% v.s. 41% from previous slide).
Source: ICAP URS December 2012
Notes: Data are only from clinics currently supported and reporting.

18. Percent patients on ART
Proportion of ART patients on second-line regimens, by country, July-September, 2012
Percent patients on ART
s33
Take home message:
There is large variability for proportion of <1 year enrolled in ART across countries. This is likely a reflection of the variation in the availability of early infant diagnosis. Note that the proportion of patients <1 year in ART care is about half of that in HIV care (22% v.s. 41% from previous slide).
Source: ICAP URS December 2012
Notes: Data are only from clinics currently supported and reporting.

19. Proportion of patients with CD4 count at baseline, 6 and 12 months after ART initiation, by country, as of September 30, 2012
Percent of patients
s38
Source: ICAP URS December 2012
Notes: This reflects cumulative cohort data for patients followed 12 months. Data are only from clinics currently supported and reporting.

20. CD4 Cell Count (cells/ul)
Median CD4 count at baseline, 6 and 12 months after ART initiation, by country, as of September 30, 2012
CD4 Cell Count (cells/ul)
s39
Source: ICAP URS December 2012
Notes: This reflects cumulative cohort data for patients followed 12 months. Baseline CD4 count is an average of 6 and 12 month cohort baseline data. Data are only from clinics currently supported and reporting.

21. Status of ART patients, by country, as of September 30, 2012
Percent of ART patients
Reported dead S
Rates are calculated as the percent of people lost to follow up, dead, or stopped ART, per person year on ART.
Source: ICAP URS December 2012
Notes: Includes adults and children, and patients who transferred out while on ART. Data are only from clinics currently supported and reporting.

22. Number of care and treatment providers trained,
by country, as of September 30, 2012
Number or providers
S42
Take home message:
As explained in the previous slide, the majority of those who discontinued ART were lost to follow up. In Kenya and Lesotho, the proportion of lost to follow up among all those have discontinued treatment were very high at 76 and 74%
Source: ICAP URS December 2012
Notes: Data are only from clinics currently supported and reporting.

23. Care and treatment clinic characteristics
Country
Clinics supported
Clinics reporting
Côte d’Ivoire 64 63
DR Congo 17
Ethiopia 85 75
Kenya
237
221
Mozambique 66
Nigeria 43 42
Rwanda 48
South Africa
102 80
Swaziland 59
Tanzania
127
TOTAL
848
796 (94%)
Source: ICAP Care and treatment PFaCTS Round 6, December 2012.

24. Geographic location and type of facility (n=796)
Percent of clinics S4
Source: ICAP Care and treatment PFaCTS Round 6, December 2012.
Note: Urban = officially designated cities with city administration and political bodies; Semi-urban = large and small towns, peri-urban areas, growth points and mining communities; Rural = subsistence and commercial farming areas.

25. Geographic location of care and treatment clinics, by country
Percent of clinics
country
Source: ICAP Care and treatment PFaCTS Round 6, December 2012.
Note: Urban = officially designated cities with city administration and political bodies; Semi-urban = large and small towns, peri-urban areas, growth points and mining communities; Rural = subsistence and commercial farming areas.

26. Proportion of HIV care and treatment clinics offering patient support services (n=789)
Percent of clinics s8
Source: ICAP Care and treatment PFaCTS Round 6, December 2012.
Notes: ART adherence counseling: Verbal patient education provided by trained personnel at least every 3 months. Outreach: patients who miss clinic follow-up or medication pick up visits are identified and contacted by facility personnel. Nutritional treatment or support for children/infants: provision of nutritional supplements or weaning foods. Nutritional treatment for adults: provision of nutritional supplements or therapeutic foods, e.g. Plumpy’Nut. Food rations: provision of rations, e.g. snacks or food packets to promote ART adherence or household food security.

27. Proportion of facilities offering laboratory assays (n=796)
Percent of facilities
s11
Source: ICAP Care and treatment PFaCTS Round 6, December 2012.
Notes: Laboratory services offered: Within the facility:  specimen collection and testing done within this facility.
At another facility: specimen collection done within this facility and testing conducted at another facility or both specimen collection and testing are conducted at another facility. Clinical chemistry includes creatinine and liver enzyme tests.

28. Mean number of providers
Mean number of full-time health care providers at HIV care and treatment clinics, by country (n=787)
Mean number of providers
S15
Take home message:
There is wide variability in number of providers in ICAP supported countries. Overall, an average of 4 health care providers provided services to patients at ICAP-supported facilities. Health care providers include three categories of staff: physicians, health officer/medical assistants, and nurses. Nurses represent the majority of health care providers in all countries.
Source: ICAP Care and treatment PFaCTS Round 6, December 2012.

29. Proportion of HIV care and treatment clinics where nurses prescribe ARVs, by country (n=790)
Percent of clinics
s11a
Source: ICAP Care and treatment PFaCTS Round 6, December 2012.

30. PMTCT Indicators

31. PMTCT clinics ever supported

32. Number of pregnant women attending ANC and receiving HIV testing, April 2007 – September 2012
As of September 2012:
2,976,011 attending ANC
2,469,039 HIV tested
2,687 clinics
Number of women
Number of clinics
Pm Eth, Moz, Nig, Taz, Apr 07, CI Jan 08, Tan Apr 08, CI Oct 08, SA Jan 09, Ken apr 10
Source: ICAP URS December 2012.
Notes: Data from clinics ever supported.

33. PMTCT clinics currently supported

34. PMTCT clinics reporting
as of September 30, 2012
Country
Clinics supported
Clinics reporting
Côte d’Ivoire 28
DRC
154
110
Ethiopia
281
275
Kenya
702
649
Mozambique
202
Nigeria 51
Rwanda
South Africa
Swaziland 62
Tanzania
616
584
TOTAL
2129
1697 (80%)
Source: ICAP URS December 2012

35. Number of pregnant women attending ANC and receiving HIV testing, April 2007 – September 2012
As of September 2012:
3,431,003 attending ANC
2,862,948 HIV tested
2,809 clinics
Number of women
Number of clinics
Pm Eth, Moz, Nig, Taz, Apr 07, CI Jan 08, Tan Apr 08, CI Oct 08, SA Jan 09, Ken apr 10
Source: ICAP URS December
Notes: Data are only from clinics currently supported and reporting.

36. Type of ART regimen for PMTCT, by country,
July-September 2012
Percent of women
pm4format
Source: ICAP URS December 2012.
Notes: Multi-drug regimens include AZT/sd-NVP, AZT/3TC tail postpartum, HAART at 34 weeks. Data are only from clinics currently supported and reporting.

37. Type of ART regimen for PMTCT, by quarter, as of September 30, 2012
Percent of women
Source: ICAP URS December 2012
Notes: Multi-drug regimens include AZT/sd-NVP, AZT/3TC tail postpartum, HAART at 34 weeks.
Data are only from clinics currently supported and reporting.

38. Proportion of HIV+ pregnant women assessed for ART eligibility, as of September 30, 2012
Percent of women
Source: ICAP URS December 2012
Notes: Multi-drug regimens include AZT/sd-NVP, AZT/3TC tail postpartum, HAART at 34 weeks. Data are only from clinics currently supported and reporting.

39. ART eligibility and initiation of ART among
HIV+ pregnant women, by country,
as of September 30, 2012
Number of women
Pm6- Swaz?!
Source: ICAP URS December 2012
Notes: Data is not available for all indicators in all countries. ART eligibility assessed through clinical staging or CD4. Newly initiating ART includes women in ANC or care and treatment clinics. Data are only from clinics currently supported and reporting.

40. HIV-exposed infants, by country, July-September 2012
Number of infants
pm8
Source: ICAP URS December 2012
Notes: Data is not available for all indicators in all countries. N=HIV exposed infants, including those born to women who tested positive in ANC and those who tested positive in maternity during the quarter. Data are only from clinics currently supported and reporting.

41. HIV-exposed infants, by country, July-September 2012
Number of infants
pm8
Source: ICAP URS December 2012
Notes: Data are not available for all indicators in all countries. N=HIV-exposed infants, including women who tested positive in ANC and those who tested positive in maternity during the quarter. Data are only from clinics currently supported and reporting.

42. TB screening in HIV care and treatment clinics

43. Care and treatment clinics ever supported for TB screening

44. Number of new HIV patients screened for TB, April 2007-September 2012
As of September 2012:
880,260 enrolled in care
504,018 TB screened
1,310 clinics
Number of patients
Number of clinics
Pm Eth, Moz, Nig, Taz, Apr 07, CI Jan 08, Tan Apr 08, CI Oct 08, SA Jan 09, Ken apr 10
Source: ICAP URS December 2012.
Notes: Data are from clinics that ever reported.

45. Care and treatment clinics currently supported for TB screening

46. TB Screening in HIV Care Settings
as of September 30, 2012
Country
Clinics supported
Clinics reporting
Côte d’Ivoire 24
DR Congo 17 12
Ethiopia
281
250
Lesotho
128
Kenya
249
Mozambique 77 64
Nigeria
Rwanda
South Africa
Swaziland 62
Tanzania
127
109
TOTAL
966
708 (73%)
Source: ICAP URS December 2012

47. Number of new HIV patients screened for TB, as of September 2012
540,197 enrolled in care
273,823 TB screened
708 clinics
Number of patients
Number of clinics
Pm Eth, Moz, Nig, Taz, Apr 07, CI Jan 08, Tan Apr 08, CI Oct 08, SA Jan 09, Ken apr 10
Source: ICAP URS December 2012.
Notes: Data are only from clinics currently supported and reporting.

48. Proportion of new HIV patients symptom screened for TB, by quarter, as of September 30, 2012
Percent of patients
S54 n=24,705 n=32,184 n=29,286 n=33,184 n=33,049 n=34,069 n=34,783 n=38,722 n=36,180 n=35,229 n=39,762 n=27,377 n=23,441 n=41,084
Source: ICAP URS December 2012
Note: Data are only from clinics currently supported and reporting. As of September 2010, new HIV care patients excludes patients who knew their TB status at enrollment.

49. Proportion of new HIV patients symptom screened for TB, by country, July-September 2012
Percent of patients
s53
Source: ICAP URS December 2012
Notes: Data are only from clinics currently supported and reporting. New HIV care patients excludes patients who knew their TB status.

50. Proportion of all new HIV patients diagnosed with TB and treated, by country, July-September 2012
Percent of patients
S58
Source: ICAP URS December 2012
Notes: Denominator does not exclude patients who knew their TB status.

51. HIV testing in TB clinics

52. TB clinics ever supported

53. Cumulative number of new TB patients tested for HIV, as of September 2012
231,563 HIV tested
1,053 clinics
Number of people
Number of clinics
Pm Eth, Moz, Nig, Taz, Apr 07, CI Jan 08, Tan Apr 08, CI Oct 08, SA Jan 09, Ken apr 10
Source: ICAP URS December
Notes: Data are from clinics ever supported.

54. TB clinics currently supported

55. HIV testing in TB clinics,
as of September 30, 2012
Country
Clinics supported
Clinics reporting
Côte d’Ivoire 7
DR Congo 29 25
Ethiopia
223
222
Kenya
300
298
Lesotho 17
Mozambique 69
Nigeria 8 6
Rwanda 2
South Africa 92
TOTAL
747
644 (86%)
Source: ICAP URS December 2012

56. Cumulative number of new TB patients tested for HIV, as of September 2012
162,533 HIV tested
628 clinics
Number of people
Number of clinics
trendtb
Source: ICAP URS December
Notes: Data are only from clinics currently supported and reporting.

57. Proportion of new TB patients with documented HIV status, as of September 30, 2012
Percent of patients
s63
Source: ICAP URS December 2012
Notes: Data are only from clinics currently supported and reporting

58. Proportion of new TB patients with documented HIV status, by country, July-September 2012
Percent of patients
s65
Source: ICAP URS December 2012.
Notes: Data are only from clinics currently supported and reporting. A documented HIV status in the TB register is the sum of patients with a known status at enrollment into TB care and those newly tested for HIV at the TB clinic

59. Proportion of new TB patients with documented status who were HIV+, by country, July-September 2012
Percent of patients
s66
Source: ICAP URS December 2012.
Notes: Data are only from clinics currently supported and reporting. A documented HIV status in the TB register is the sum of patients with a known status at enrollment into TB care and those newly tested for HIV at the TB clinic

60. Proportion of TB patients co-infected with HIV who enrolled in HIV care, by country, July-September 2012
Percent of patients
s66
Source: ICAP URS December 2012.
Notes: Data are only from clinics currently supported and reporting

61. HIV testing and counseling

62. Facilities with testing and counseling ever supported

63. Number of people tested for HIV, as of September 2012
6,624,929 HIV tested
370,997 HIV+
1,452 facilities
Number of people
Number of clinics
Pm Eth, Moz, Nig, Taz, Apr 07, CI Jan 08, Tan Apr 08, CI Oct 08, SA Jan 09, Ken apr 10
Source: ICAP URS December 2012.
Notes: Data are only from clinics currently supported and reporting.

64. Facilities with testing and counseling currently supported

65. Counseling and testing,
as of September 31, 2012
Country
Clinics supported
Clinics reporting
Côte d’Ivoire 30
DR Congo 37 21
Ethiopia
278
277
Kenya
163
158
Mozambique
113 60
Nigeria 33
Rwanda
South Africa
Tanzania
316
TOTAL
970
862 (89%)
Source: ICAP URS December 2012

66. Number of people tested for HIV, as of September 2012
4,786,685 HIV tested
206,262 HIV+
862 facilities
Number of people
Number of clinics
Pm Eth, Moz, Nig, Taz, Apr 07, CI Jan 08, Tan Apr 08, CI Oct 08, SA Jan 09, Ken apr 10
Source: ICAP URS December 2012.
Notes: Data are only from facilities currently supported and reporting.

67. Number of points of service
Number of points of service reporting, by country, January-September 2012
Number of points of service
tc8
Source: ICAP URS Decemberr 2012
Notes: Data are only from clinics currently supported and reporting.

68. Number of patients counseled and tested, by point of service, July-September 2012
Most data from VCT clinics comes from Ethiopia, which may decrease the overall prevalence found in VCT clinics.
Source: ICAP URS December 2012
Notes: Other includes: laboratory; family planning, well-baby, STI, and TB clinics; casualty/trauma; palliative care/hospice; customer care, cervical cancer screening; HIV care / ART (family testing); blood donation center; and other points of service. Countries or facilities who do not disaggregate testing data by point of service are listed under all points of service.

69. Proportion of patients
Proportion of patients tested who were HIV+ and enrolled in care, by point of service,
July-September 2012
Proportion of patients
Most data from VCT clinics comes from Ethiopia, which may decrease the overall prevalence found in VCT clinics.
Source: ICAP URS December 2012
Notes: Other includes: laboratory; family planning, well-baby, STI, and TB clinics; casualty/trauma; palliative care/hospice; customer care, cervical cancer screening; HIV care / ART (family testing); blood donation center; and other points of service. Countries or facilities who do not disaggregate testing data by point of service are listed under all points of service.

70. Number of patients counseled and tested, HIV+ and enrolled in care, by country, January-September 2012
Number of patients
tc8
Source: ICAP URS December 2012

71. Proportion of patients
Proportion of patients tested who were HIV+ and enrolled in care, by country,
July-September 2012
Proportion of patients
Most data from VCT clinics comes from Ethiopia, which may decrease the overall prevalence found in VCT clinics.
Source: ICAP URS December 2012

72. Clinical laboratories
Clinical laboratories are defined by PEPFAR as having:
Dedicated laboratory personnel
Capacity to diagnose HIV with rapid test, EIA or molecular methods
Capacity to perform clinical laboratory tests in at least one of the following areas: hematology, clinical chemistry, serology, microbiology, CD4 testing / viral load, TB diagnostic identification, malaria infection diagnosis, OI diagnosis.

73. Clinical laboratories ever supported

74. Number of tests conducted, by type of test, as of September 30, 2012
1,132,966 CD4 count
609 laboratories
438,884 CD4 %
1,658,066 HIV rapid tests
392,414 AFB
Number of tests
Number of laboratories
Pm Eth, Moz, Nig, Taz, Apr 07, CI Jan 08, Tan Apr 08, CI Oct 08, SA Jan 09, Ken apr 10
Source: ICAP URS December 2012.
Notes: Data are from labs ever supported.

75. Clinical laboratories currently supported

76. Clinical Laboratories
as of September 30, 2012
Country
Facilities supported
Facilities reporting
Côte d’Ivoire 9
DR Congo 6
Ethiopia 89
Kenya
204
166
Mozambique 66
Nigeria
Rwanda
South Africa
Tanzania
148 97
TOTAL
522
272 (52%)
Source: ICAP URS December 2012

77. Number of tests conducted, by type of test, as of September 30, 2012
272 laboratories
266,991 CD4 %
995,694 HIV rapid tests
254,623 AFB
690,792 CD4 count
Number of tests
Number of laboratories
Pm Eth, Moz, Nig, Taz, Apr 07, CI Jan 08, Tan Apr 08, CI Oct 08, SA Jan 09, Ken apr 10
Source: ICAP URS December 2012.
Notes: Data are only from labs currently supported and reporting.

78. HIV-related tests conducted by country,
July-September 2012
Number of tests
Source: ICAP URS December 2012
Note: Data are only from clinics currently supported and reporting

79. Characteristics of clinical laboratories

80. Laboratories supported Laboratories reporting
Laboratory characteristics
Country
Laboratories supported
Laboratories reporting
Côte d’Ivoire 7 16
DR Congo 5 6
Ethiopia 89 80
Kenya
213
175
Mozambique 66 53
Nigeria 8 32
Rwanda 47
South Africa
Tanzania
148
112
TOTAL
542
521 (96%)
Source: ICAP Lab PFaCTS Round 1, September 2011

81. Number of laboratories, by country (n=521)
Source: ICAP Lab PFaCTS Round 1, September 2011

82. Type of laboratory support provided by ICAP (n=521)
Percent of laboratories
Source: ICAP Lab PFaCTS Round 1, September 2011

83. Proportion of laboratory tests conducted, by type of test (n=521)
Percent of laboratories
Source: ICAP Lab PFaCTS Round 1, September 2011

84. Co-location of equipment with general laboratory equipment (n=521)
Percent of laboratories
Source: ICAP Lab PFaCTS Round 1, September 2011

85. Percent of laboratories
Proportion of laboratories that support lab tests at other points of service in the facility
Percent of laboratories s8
Source: ICAP Lab PFaCTS Round 1, September 2011

86. Percent of laboratories
Proportion of laboratories with regular power outages that have backup generators, by country
Percent of laboratories
Source: ICAP Lab PFaCTS, December 2012

87. Percent of laboratories
Proportion of laboratories with supply shortages in the past year, by type of shortage and country
Percent of laboratories
Source: ICAP Lab PfaCTS, December 2012

88. For more information, please see:
ICAP URS
ICAP Data Dissemination Page
Care and treatment PFACTS country reports
Lab PFACTS country reports